SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition
SEC Accession No. 0001193125-11-271464
Filing Date
2011-10-14
Accepted
2011-10-14 13:07:50
Documents
4
Period of Report
2011-10-14
Filing Date Changed
2011-10-14

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY NOTICE & PROXY STATEMENT d237724dprem14a.htm PREM14A 1582450
2 GRAPHIC g237724g16c56.jpg GRAPHIC 7877
3 GRAPHIC g237724g55z23.jpg GRAPHIC 8394
4 GRAPHIC g237724g72k66.jpg GRAPHIC 5805
  Complete submission text file 0001193125-11-271464.txt   1614336
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 000-27570 | Film No.: 111141366
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1